Home › Funds › GLAZER CAPITAL, LLC › CPRX
GLAZER CAPITAL, LLC position in CPRX
CATALYST PHARMACEUTICALS INC
GLAZER CAPITAL, LLC reported holding 3,602,865 shares of CPRX (CATALYST PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$113.2M, representing 3.38% of its reported portfolio and ranking #4 among its reported holdings. GLAZER CAPITAL, LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GLAZER CAPITAL, LLC's CPRX position evolved
GLAZER CAPITAL, LLC first disclosed a stake in CPRX in Q2 2026 at 3,602,865 shares (US$113.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 3.60M | $113.24M | New |
About CPRX and 13F data
CPRX (CATALYST PHARMACEUTICALS INC) is a company whose sector is not yet classified in our data. 42 other funds we track also report a position in CPRX — the largest reported positions include HBK INVESTMENTS L P (US$88.6M), NEXPOINT ASSET MANAGEMENT, L.P. (US$50.4M), Polar Asset Management Partners Inc. (US$36.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CPRX
- HBK INVESTMENTS L P 2.82M sh · $88.64M · Q2 2026
- NEXPOINT ASSET MANAGEMENT, L.P. 1.60M sh · $50.37M · Q2 2026
- Polar Asset Management Partners Inc. 1.15M sh · $36.15M · Q2 2026
- WATER ISLAND CAPITAL LLC 933.82K sh · $29.35M · Q2 2026
- KENNEDY CAPITAL MANAGEMENT LLC 856.61K sh · $26.92M · Q2 2026
- Sagefield Capital LP 569.48K sh · $17.90M · Q2 2026
More on GLAZER CAPITAL, LLC
FAQ
How long has GLAZER CAPITAL, LLC held CPRX?
GLAZER CAPITAL, LLC has disclosed CPRX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is GLAZER CAPITAL, LLC's current position in CPRX?
As of Q2 2026, GLAZER CAPITAL, LLC holds 3.60M shares of CPRX (CATALYST PHARMACEUTICALS INC), valued at $113.24M, representing 3.38% of its reported portfolio and ranking #4.
Has GLAZER CAPITAL, LLC been buying or selling CPRX?
In the latest 13F filing (Q2 2026), GLAZER CAPITAL, LLC newly opened its position in CPRX.
Which other funds hold CPRX?
Other major institutional holders of CPRX include HBK INVESTMENTS L P, NEXPOINT ASSET MANAGEMENT, L.P., Polar Asset Management Partners Inc., among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.